Epizyme, Inc.
Method for treating cancer
Last updated:
Abstract:
The present invention relates to pharmaceutical compositions comprising inhibitor(s) of human histone methyltransferase EZH2, and methods of cancer therapy using the EZH2 inhibitor(s).
Status:
Grant
Type:
Utility
Filling date:
17 Nov 2015
Issue date:
29 Sep 2020